BPIQ Blog

Jun 18, 20181 min read

AMRN; a Q3 Pick and Possible Run-Up

For Q3 2018, one of our picks is AMRN as a run-up play before data read-out. They have an approved drug for cardiovascular health and...

Jun 1, 20183 min read

ASCO 2018 Amp Noteworthy Abstracts

At Amp, we research biopharma companies primarily with valuations between $200M and $5B, who have upcoming catalyst events in the next 12...

May 21, 20181 min read

NBRV down 16.6% Today - Market Remains Tough on Companies Developing New Antibiotics

The market has been very tough on small cap companies developing novel anti-microbials (e.g. antibiotics) since this past fall (See CDTX...

Apr 13, 20187 min read

AACR 2018 Amp Up

As the annual meeting for the American Association of Cancer Research kicks off this weekend and runs into early next week, we have been...

Jump start your biotech due diligence

Our platform helps you uncover your next biotech investment opportunity